Early prediction of sepsis-induced respiratory tract infection using a biomarker-based machine-learning algorithm.

Journal: Scandinavian journal of clinical and laboratory investigation
Published Date:

Abstract

Early and differential diagnosis of sepsis is essential to avoid unnecessary antibiotic use and further reduce patient morbidity and mortality. Here, we aimed to identify predictors of sepsis and advance a machine-learning strategy to predict sepsis-induced respiratory tract infection (RTI). Patients with sepsis and RTI were selected via retrospective analysis, and essential population characteristics and laboratory parameters were recorded. To improve the performance of the primary model and avoid over-fitting, a recursive feature elimination with cross-validation (RFECV) strategy was used to screen the optimal subset of biomarkers and construct nine machine-learning models based on this subset; the average accuracy, precision, recall, and F1-score were used for evaluation of the models. We identified 430 patients with sepsis and 686 patients with RTI. A total of 39 features were collected, with 23 features identified for initial model construction. Using the RFECV algorithm, we found that the XGBoost classifier, which only needed to include seven biomarkers, demonstrated the best performance among all prediction models, with an average accuracy of 89.24 ± 2.28, while the Ridge classifier, which included 11 biomarkers, had an average accuracy of only 83.87 ± 4.69. The remaining models had prediction accuracies greater than 88%. We developed nine models for predicting sepsis using a strategy that combined RFECV with machine learning. Among these models, the XGBoost classifier, which included seven biomarkers, showed the best performance and highest accuracy for predicting sepsis and may be a promising tool for the timely identification of sepsis.

Authors

  • Mingkuan Su
    Department of Laboratory Medicine, Mindong Hospital of Ningde City, Fuan City, China mingkuansu@qq.com 22539160@qq.com.
  • Haiying Wu
    From the Hypertension Center (X.W., W.W., K.L., Y.Q., X.S., W.M., Y.Z., H.Z., X.Z., H.W., X.J., J.C., L.S.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Hongbin Chen
    Department of Laboratory Medicine, Mindong Hospital of Ningde City, Fuan City, China.
  • Jianfeng Guo
    Shenzhen Ecology and Environment Monitoring Centre of Guangdong Province, Shenzhen 518049, China.
  • Zongyun Chen
    Department of Laboratory Medicine, Mindong Hospital of Ningde City, Fuan City, China.
  • Jie Qiu
    Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Electronic address: qiujie@pumch.cn.
  • Jiancheng Huang
    Department of Laboratory Medicine, Mindong Hospital of Ningde City, Fuan City, China.